Author

P. Suri

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

D. A. Lukow· 1 shared E. L. Sausville· 1 shared G. J. Britton· 1 shared I. Mogno· 1 shared J. J. Faith· 1 shared J. Kendall· 1 shared J. Leu· 1 shared J. M. Sheltzer· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

D. A. Lukow

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Species-specific CD4+ T cells Enable Prediction of Mucosal Immune Phenotypes from Microbiota Composition

M. P. Spindler, I. Mogno, P. Suri, G. J. Britton, J. J. Faith

The paper identifies bacterial strains that drive specific mucosal T cell phenotypes using gnotobiotic mice and ex vivo assays, showing strain-specific T cell responses.

bioRxiv · Aug 13, 2022 · PreprintImmunology

Chromosomal instability accelerates the evolution of resistance to anti-cancer therapies

D. A. Lukow, E. L. Sausville, P. Suri, N. K. Chunduri, J. Leu, J. Kendall, Z. Wang, Z. Storchova, J. M. Sheltzer

This study shows that chromosomal instability accelerates cancer cell adaptation to anti-cancer therapies by enabling specific aneuploidy events that reduce drug sensitivity.

bioRxiv · Sep 25, 2020Cancer Biology